Trial NCT03168594

View at ClinicalTrials.gov 
Org. Study IDs: EP vs. IP

Last trial update was posted on 2020-01-22

MeSH Interventions

Cisplatin Etoposide Irinotecan

MeSH Conditions

Carcinoma Carcinoma, Neuroendocrine

Other Conditions

Neuroendocrine Carcinoma

Stopping Reasons

The enrollment was terminated early because the premature analysis found similar response in the two arms.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID